SOURCE: American Diabetes Association

American Diabetes Association

June 10, 2012 14:15 ET

Diabetes Care Launches Annual Symposium Showcasing State-of-the-Art, Leading Diabetes Research

Journal to Publish Studies, Articles Presented in Special Section of July Issue

PHILADELPHIA, PA--(Marketwire - Jun 10, 2012) - Researchers representing six teams whose work will be published in a special section of the July issue of Diabetes Care, the journal of the American Diabetes Association, presented their findings on a wide range of landmark diabetes trials and innovative, clinical and translational studies challenging current paradigms of diabetes treatment and evolving clinical management strategies, during the first-ever Diabetes Care Symposium at the American Diabetes Association's 72nd Scientific Sessions®.

The manuscripts were selected from 150 articles submitted for consideration for the Symposium, which will become an annual event at the Association's scientific meetings, held each year to make public the latest research on diabetes prevention and treatment from around the world. Researchers may begin submitting manuscripts for consideration for next year's Symposium in the fall.

"The Symposium gives us the opportunity to highlight some of the truly innovative and ground-breaking research being published in Diabetes Care, and is part of our ongoing efforts to remain on the cutting edge of science and technology," said Diabetes Care Editor William T. Cefalu, MD, who is also Associate Executive Director of Clinical Research at Pennington Biomedical Research Center in Baton Rouge, LA. "It is part of a number of new initiatives for the journal which now includes easy access for data dissemination. Specifically, the Association has implemented a free, monthly podcast highlighting research published in Diabetes Care, Clinical Diabetes and Diabetes Spectrum, the Association's three medical journals, and the creation of mobile-optimized websites for viewing these journals on smart phones and other mobile devices."

The Association also recently launched an ADA Journals Facebook page and Twitter profile (@ADA_Journals) to provide researchers with additional vehicles for promoting and disseminating their research via social media. These and other changes are outlined in an editorial by Cefalu published in the July issue of Diabetes Care.

The six studies highlighted in oral presentations at the Symposium included:

  • "Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Persons with Diabetes (The ACCORD Blood Pressure Trial)," which found that intensively lowering blood pressure versus standard treatment resulted in no improvement in cardiovascular risk for people with type 2 diabetes.
  • "Diabetic Ketoacidosis at Diagnosis Influences Complete Remission After Treatment of Hematopoietic Stem Cell Transplantation in Adolescents with Type 1 Diabetes," which found autologous nonmyeloablative hematopoietic stem cell transplantation to be an effective long-term treatment of insulin dependence with greater efficacy achieved in patients without ketoacidosis at diagnosis.
  • "Beta Cell Function Preservation After 3.5 Years of Intensive Diabetes Therapy," which found that pancreatic (Beta-cell) function can be preserved for at least 3.5 years with early and intensive therapy for type 2 diabetes with either insulin or triple oral therapy (metformin, glyburide and pioglitazone) after an initial 3-month insulin-based treatment.
  • "Effects of Gastric Bypass Surgery in Patients with Type 2 Diabetes and Only Mild Obesity," which found that this type of surgery was a safe and effective means of reducing A1C and associated co-morbidities, such as cardiovascular risk, in those who had type 2 diabetes but were only mildly obese. The lower BMI cutpoint for surgery was also discussed in a commentary in the journal.
  • "Liver Fat is Reduced by an Isoenergetic MUFA Diet in a Controlled, Randomized Study in Type 2 Diabetes Patients," which found that an isocaloric diet enriched in monounsaturated fatty acids (commonly thought to be healthy fats and found in foods such as olive oil and avocados) compared to a diet higher in carbohydrate and fiber was associated with a clinically relevant reduction of hepatic fat content in type 2 diabetes, suggesting that this should be considered for the nutritional management of people with type 2 diabetes and fatty liver disease.
  • "Improving Outcomes in Clinical Islet Transplantation: 1999-2010," which found that there was steady improvement in primary outcomes of islet transplantation in recipients transplanted in 2007-2010 compared to those transplanted in 1999-2006, with fewer islet infusions.

Diabetes Care Symposium: Sunday June 10, 2:15 p.m. ET, Grand Ballroom B

Diabetes Care, published by the American Diabetes Association, is the leading peer-reviewed journal of clinical research into one of the nation's leading causes of death by disease. Diabetes also is a leading cause of heart disease and stroke, as well as the leading cause of adult blindness, kidney failure, and non-traumatic amputations.

The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. Founded in 1940, our mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.

Contact Information

  • Contact:
    Christine Feheley
    (703) 253-4374
    Colleen Fogarty
    (703) 549-1500, ext. 2146

    News Room: June 8-12, 2012
    Room 107, Pennsylvania Convention Center
    (215) 418-2030

Webosphere

Keyword Cloud

View Website